MedTrace Logo

Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II

NCT00089882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2009-07-23

No results posted yet for this study

Summary

The REVEAL II study provides healthy adult children and siblings of Alzheimer's disease patients with genetic testing and information about their own chances of developing the disease. The study will compare a condensed education and counseling program to the current more extensive program.

Conditions

  • Alzheimer Disease

Interventions

PROCEDURE

APOE Genetic susceptibility testing

Sponsors & Collaborators

  • National Human Genome Research Institute (NHGRI)

    collaborator NIH

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Robert C. Green, MD, MPH · Boston University School of Medicine, Genetics Program and Alzheimer's Disease Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-05-31
Primary Completion
2006-09-30
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00089882 on ClinicalTrials.gov